1.Wilhelm SM，Simonson MS，Robinson AV，et al.Endothelin up regulation and localization following renal ischemic and reperfusion.Kidney Int，1999，55：1011-1015.

2.Ruschitzka F，Shaw S，Gygi D，et al.Endothelin dysfunction in acute renal failure：role of circulating and tissue endothelin-1.JAm Soc Nephrol，1999，10：953-956.

3.Malek M，Nematbakhsh M.Renal ischemia/reperfusion injury：from pathophysiology to treatment.J Renal Inj Prev，2015，4：20-27.

4.Mehta RL.Renal replacement therapy in the critically iIl：does timing matter？N Engl JMed，2016，375（2）：175-176.

5.KDIGO AKIWork Group.KDIGO clinical practice guideline for acute kidney injury.Kidney Int Suppl，2012，2：1-138.

6.Abuelo JG.Normotensive ischemic acute renal failure.N Engl JMed，2005，357：797-805.

7.Munshi R，Hsu C，Himmelfarb J.Advances in understanding ischemic acute kidney injury.BMC Med，2011，9：11.

8.Chuang CL.Fluid management in acute kidney injury.Contrib Nephrol，2016，187：84-93.

9.Chopra TA，Brooks CH，Okusa MD.Acute kidney injury prevention.Contrib Nephrol，2016，187：9-23.

10.Vanmassenhove J，Veys N，Van Biesen W.Prevention and conservative management of acute kidney injury.Minerva Urol Nefrol，2016，68：58-71.

11.Martin GS，Mannino DM，Eaton S，et al.The epidemiology of sepsis in the United States from 1979 through 2000.N Engl JMed，2003，348：1546-1554.

12.Oppert M，Engel C，Brunkhorst FM，et al.Acute renal failure in patients with severe sepsis and septic shock-a significant independent risk factor formortality：results from the German prevalence study.Nephrol Dial Transplant，2008，23：904-909.

13.Lopes JA，Jorge S，Resina C，et al.Acute renal failure in patients with sepsis.Crit Care，2007，11：411.

14.Uchino S，Kellum JA，Bellomo R，et al.Acute renal failure in critically ill patients：amultinational，multicenter study.JAMA，2005，294：813-818.

15.Dellinger RP，Levy MM，Rhodes A，et al.Surviving sepsis campaign：international guidelines formanagementof severe sepsis and septic shock：2012.Crit Care Med，2013，41：580-637.

16.Gomez H，Ince C，De Backer D，et al.A unified theory of sepsis-induced acute kidney injury：inflammation，microcirculatory dysfunction，bioenergetics，and the tubular cell adaptation to injury.Shock，2014，41：3-11.

17.Zarbock A，Gomez H，Kellum JA.Sepsis-induced acute kidney injury revisited：pathophysiology，prevention and future therapies.Curr Opin Crit Care，2014，20：588-595.

18.Langenberg C，Bellomo R，May C，et al.Renal blood flow in sepsis.Crit Care，2005，9：R363-374.

19.Benes J，Chvojka J，Sykora R，etal.Searching formechanisms thatmatter in early septic acute kidney injury：an experimental study.Crit Care，2011，15：R256.

20.Prowle JR，Kirwan CJ，Bellomo R.Fluid management for the prevention and attenuation of acute kidney injury.Nat Rev Nephrol，2014，10：37-47.

21.Sprague AH，Khalil RA.Inflammatory cytokines in vascular dysfunction and vascular disease.Biochem Pharmacol，2009，78：539-552.

22.Aksu U，Demirci C，Ince C.The pathogenesis of acute kidney injury and the toxic triangle of oxygen，reactive oxygen species and nitric oxide.Contrib Nephrol，2011，174：119-128.

23.Heemskerk S，Masereeuw R，Russel FG，et al.Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury.Nat Rev Nephrol，2009，5：629-640.

24.Tiwari MM，Brock RW，Megyesi JK，et al.Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure：role of nitric oxide and caspases.Am JPhysiol Renal Physiol，2005，289：F1324-F1332.

25.Herter JM，Rossaint J，Spieker T，et al.Adhesion molecules involved in neutrophil recruitment during sepsis-induced acute kidney injury.J Innate Immun，2014，6：597-606.

26.Brown KA，Brain SD，Pearson JD，et al.Neutrophils in development of multiple organ failure in sepsis.Lancet，2006，368：157-169.

27.Zarbock A，Ley K.Mechanisms and consequences of neutrophil interaction with the endothelium.Am JPathol，2008，172：1-7.

28.Morrell ED，Kellum JA，Hallows KR，et al.Epithelial transport during septic acute kidney injury.Nephrol Dial Transplant，2014，29：1312-1319.

29.SingerM，De Santis V，Vitale D，etal.Multiorgan failure is an adaptive，endocrine-mediated，metabolic response to overwhelming systemic inflammation.Lancet，2004，364：545-548.

30.Shum HP，YanWW，Chan TM.Recent knowledge on the pathophysiology of septic acute kidney injury：A narrative review.JCrit Care，2016，31：82-89.

31.Mårtensson J，Bellomo R.Pathophysiology of septic acute kidney injury.Contrib Nephrol，2016，187：36-46.

32.PatelML，Sachan R，Shyam R，etal.Diagnostic accuracy ofurinary neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury.Int JNephrol Renovasc Dis，2016，9：161-169.

33.Peng ZY，Wang HZ，Carter MJ，et al.Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis.Kidney Int，2012，81：363-369.

34.Heemskerk S，Masereeuw R，Moesker O，et al.Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients.Crit Care Med，2009，37：417-423.

35.Pickkers P，Heemskerk S，Schouten J，et al.Alkaline phosphatase for treatment of sepsis-induced acute kidney injury：a prospective randomized double blind placebo-controlled trial.Crit Care，2012，16：R14.

36.Susantitaphong P，Perianayagam MC，Tighiouart H，et al.Tumor necrosis factor alpha promoter polymorphism and severity of acute kidney injury.Nephron Clin Pract，2013，123：67-73.

37.Kellum JA，Chawla LS，Keener C，et al.The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock.Am JRespir Crit Care Med，2016，193：281-287.

38.Song YR，Lee T，You SJ，et al.Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting：a pilot study.Am JNephrol，2009，30：253-260.

39.Susantitaphong P，Cruz DN，Cerda J，et al.World incidence of AKI：a meta-analysis.Clin JAm Soc Nephrol，2013，8：1482-1493.

40.Lerolle N，Guerot E，Faisy C，etal.Renal failure in septic shock：predictive value of Doppler-based renal arterial resistive index.Intensive Care Med，2006，32：1553-1559.

41.Schnell D，Darmon M.Bedside Doppler ultrasound for the assessmentof renal perfusion in the ICU：advantages and limitations of the available techniques.Crit Ultrasound J，2015，7：24.

42.Schneider AG，Goodwin MD，Schelleman A，et al.Contrast-enhanced ultrasonography to evaluate changes in renal corticalmicrocirculation induced by noradrenaline：a pilot study.Crit Care，2014，18：653.

43.Faubel S，Patel NU，Lockhart ME，et al.Renal relevant radiology-use of ultrasonography in patients with AKI.Clin JAm Soc Nephrol，2014，9：382-394.

44.Cauwenberghs N，Kuznetsova T.Determinants and prognostic significance of the renal resistive index.Pulse（Basel），2016，3：172-178.

45.Schnell D，Deruddre S，Harrois A，etal.Renal resistive index better predicts the occurrence of acute kidney injury than cystatin C.Shock，2012，38：592-597.

46.Deruddre S，Cheisson G，Mazoit JX，et al.Renal arterial resistance in septic shock：effects of increasingmean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography.Intensive Care Med，2007，33：1557-1562.

47.Lauschke A，Teichgraber UK，Frei U，et al.Low-dose dopamine worsens renal perfusion in patients with acute renal failure.Kidney Int，2006，69：1669-1674.

48.Verbrugge FH，Grieten L，Mullens W.Management of the cardiorenal syndrome in decompensated heart？failure.Cardiorenal Med，2014，4：176-188.

49.Naesens M，Heylen L，Lerut E，et al.Intrarenal resistive index after renal transplantation.N Engl JMed，2013，369：1797-1806.

50.SEPSISPAM Investigators.Asfar P，Meziani F，Hamel JF，et al.High versus low blood-pressure target in patientswith septic shock.N Engl JMed，2014，370：1583-1593.

51.Wang L，Mohan C.Contrast-enhanced ultrasound：A promising method for renal microvascular perfusion evaluation.JTransl IntMed，2016，4：104-108.

52.Schneider AG，Goodwin MD，Schelleman A，et al.Contrast-enhanced ultrasonography to evaluate changes in renal corticalmicrocirculation induced by noradrenaline：a pilot study.Crit Care，2014，18：653.